Guide

Stopping a GLP-1 and keeping the weight off

The exit takes six weeks. The keeping takes a year, runs on four boring systems, and is the part almost nobody prepares for. This is the season after the season.

MaintenanceApplies to Ozempic, Wegovy, Zepbound, Mounjaro and compounded GLP-1sUpdated August 2026

The event and the season

Stopping a GLP-1 has two phases that get collapsed into one word. The exit is the six-week event: drug levels fading, the week-one water jump, the weeks three to six appetite rebound. It is intense, dated, and well mapped; we cover it step by step in getting off a GLP-1 without gaining the weight back. The keeping is the season after: months two through twelve, when the drama is over, attention drifts, and the trial data says most regain quietly accumulates, a few pounds a month, not a sudden collapse.

Real-world outcomes split almost evenly: in Cleveland Clinic data on ~8,000 stoppers, about 45% maintained or kept losing at one year while the rest regained. The maintainers were not genetically blessed. Maintenance research going back decades, long before GLP-1s, keeps finding the same short list of behaviors, and the GLP-1 exit changes the timing but not the list.

The four systems the 45% run

01The watched trend. Daily weigh-ins smoothed into a weekly average, judged against a line you chose in advance. Single mornings are noise; the trend is the only signal. This is the system that converts regain from an ambush into an early, small correction, caught at 4 lbs, where every option is still on the table.

02The protein floor that never became optional. Roughly 1.6g per kg of goal weight, split across three meals. On the medication it took effort; off it, appetite will finally cooperate. The floor blunts rebound hunger, protects muscle, and gives every day a fixed anchor that does not depend on motivation.

03Strength, kept small enough to survive. Two to three short full-body sessions a week, forever. Muscle sets your resting burn, and it is the difference between maintenance at a livable intake and maintenance as a permanent squeeze. The dose that works is the one that survives busy weeks: twenty minutes counts.

04The drift protocol. A pre-agreed response to a rising trend: restore the floor, tighten structure for two weeks, and a named number at which the prescriber conversation happens. Deciding the protocol in month one, while the trend is flat, is what makes month seven boring instead of frightening.

Notice what is not on the list: white-knuckle restriction, daily cardio penance, cutting entire food groups, or any behavior that requires being impressive. Maintenance selects for systems that survive ordinary life. The number for your protein floor is in the protein calculator, and your new maintenance intake, which is lower than your pre-loss instincts believe, is in the maintenance calculator.

The months, honestly

Months 1 to 2: the rebound settles and a false confidence arrives, because appetite feels manageable and the scale is flat. This is precisely when the systems get skipped for the first time. Do not negotiate with the floor or the sessions here; you are not maintaining yet, you are still exiting.

Months 3 to 6: the trial regain window. Appetite is fully back, novelty is gone, and life has reasserted itself. The trend line does the heavy lifting now: drift caught at 3 lbs in month four is a two-week correction. This is also when food noise, if it returned loud, either got a plan or started winning; the plan is in how to stop food noise.

Months 6 to 12: the identity stretch. The medication chapter feels finished and the question becomes whether the systems are who you are now or a diet you are still on. People who maintain describe the same shift: the weigh-in, the floor, and the sessions stop being effortful vigilance and become how Tuesdays work. If the trend has held this long, the data says you are most of the way to keeping it kept.

If the trend starts climbing anyway

Some seasons go sideways: an injury, a brutal work stretch, a loss. The response is the drift protocol, not a character review. Weigh daily again, restore the floor first, tighten structure for two weeks, and if the trend crosses your line, have the prescriber conversation early. Restarting medication, or stepping onto a maintenance dose, is a legitimate move made from data. The full playbook for that moment, including the drug-specific numbers, is in how to not gain the weight back and rebound weight gain.

And if anyone tells you that needing structure forever means the stopping failed: the 45% are not off the hook, they are off the medication. The biology is forever, the plan is forever, and a plan you run yourself is still a plan. That argument, in full, lives in do you have to take Ozempic forever.

Frequently asked questions

What percentage of people keep the weight off after stopping a GLP-1?

In Cleveland Clinic real-world data on roughly 8,000 discontinuers, about 45% maintained their weight or continued losing at one year. Trial extensions paint a darker picture, with about two-thirds of lost weight regained, but those participants stopped abruptly with no support. The spread between the numbers is the effect of circumstances, which is the encouraging part: circumstances can be arranged.

What do people who maintain after a GLP-1 actually do differently?

The consistent pattern across maintenance research is four systems: they keep weighing (daily readings smoothed into a weekly trend), they hold a protein floor even after appetite normalizes, they keep two to three strength sessions a week to defend the muscle that sets their burn rate, and they respond to small drift immediately instead of avoiding the scale. None of it is heroic. All of it is boring, which is why it works.

How long after stopping a GLP-1 is regain risk highest?

The physiological rebound peaks in weeks three to six as the drug fades and hunger hormones overshoot. But most actual regain accumulates in months two through twelve, quietly, a few pounds a month, during the stretch when attention fades and life gets loud again. The exit is an event; the keeping is a season. Most people over-prepare for the event and under-prepare for the season.

Does weight come back slower if you taper off a GLP-1?

No trial has compared taper against cold stop directly. A stepped exit gives appetite a slope instead of a cliff and buys practice time, which is why many prescribers favor it, but the maintenance data suggests what matters most is what is running afterward: the trend watch, the protein floor, the strength habit. A perfect taper into nothing is worse than an abrupt stop into structure.

What should I do the moment I notice regain starting?

Three moves, in order. Weigh daily again even though every instinct says avoid it, because avoidance is what turns 8 lbs into 30. Restore the protein floor before changing anything else. And if the trend keeps climbing past the line you set, book the prescriber conversation early, where restarting or a maintenance dose is a decision made from strength rather than a rescue made in panic.

Sources

  • STEP-1 extension: Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes Obes Metab, 2022.
  • SURMOUNT-4: Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction. JAMA, 2024.
  • Biggest Loser 6-year follow-up: Fothergill E et al. Persistent metabolic adaptation 6 years after "The Biggest Loser" competition. Obesity, 2016.
  • Morton et al. protein meta-analysis: Morton RW et al. Systematic review, meta-analysis and meta-regression of protein supplementation and resistance training (n=1,863). Br J Sports Med, 2018.
  • Cleveland Clinic real-world discontinuation cohort (~8,000 patients, 2026): approximately 45% maintained or continued losing at one year after stopping.
  • National Weight Control Registry: long-term maintainers share frequent self-weighing, consistent eating patterns, and regular physical activity.

Linked citations open on PubMed or DailyMed, both run by the US National Institutes of Health. Where a claim on this page comes from reporting or clinical commentary we could not resolve to a stable public record, it is listed above without a link rather than pointed at an approximation.